Viatris is a global healthcare company that develops, manufactures, and distributes a broad portfolio of medicines including generic drugs, iconic branded products, and innovative therapies to approximately one billion patients annually across more than 165 countries. The company generates revenue primarily through sales of its diverse pharmaceutical portfolio—which includes over 1,400 approved molecules spanning complex generics, well-established brands, and newer innovative medicines—to customers including retail pharmacies, wholesalers, hospitals, institutions, and governments. Viatris operates an integrated global supply chain with manufacturing and distribution facilities worldwide and employs tens of thousands of people, with strategic operations centered in the United States, Asia, and other key markets.